Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-2-27
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0268-3369
pubmed:author
pubmed:issnType
Print
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
409-10
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:18026147-Adult, pubmed-meshheading:18026147-Antibodies, Monoclonal, pubmed-meshheading:18026147-Antibodies, Monoclonal, Humanized, pubmed-meshheading:18026147-Female, pubmed-meshheading:18026147-Graft vs Host Disease, pubmed-meshheading:18026147-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:18026147-Humans, pubmed-meshheading:18026147-Immunoglobulin G, pubmed-meshheading:18026147-Immunosuppressive Agents, pubmed-meshheading:18026147-Male, pubmed-meshheading:18026147-Medical Audit, pubmed-meshheading:18026147-Methylprednisolone, pubmed-meshheading:18026147-Middle Aged, pubmed-meshheading:18026147-Retrospective Studies, pubmed-meshheading:18026147-Salvage Therapy, pubmed-meshheading:18026147-Transplantation, Homologous, pubmed-meshheading:18026147-Treatment Failure
pubmed:year
2008
pubmed:articleTitle
Daclizumab has poor efficacy in steroid-refractory severe acute graft-versus-host disease: a single centre experience with 12 allograft patients.
pubmed:publicationType
Letter